Cargando…

Identification and Validation of an Autophagy-Related lncRNA Signature for Patients With Breast Cancer

BACKGROUND: Autophagy is a “self-feeding” phenomenon of cells, which is crucial in mammalian development. Long non-coding RNA (lncRNA) is a new regulatory factor for cell autophagy, which can regulate the process of autophagy to affect tumor progression. However, poor attention has been paid to the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ruyue, Zhu, Qingwen, Yin, Detao, Yang, Zhe, Guo, Jinxiu, Zhang, Jingmin, Zhou, Yubing, Yu, Jane J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892971/ https://www.ncbi.nlm.nih.gov/pubmed/33614483 http://dx.doi.org/10.3389/fonc.2020.597569

Ejemplares similares

Biological Roles and Therapeutic Applications of IDH2 Mutations in Human Cancer
por: Guo, Jinxiu, et al.
Publicado: (2021)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Identification and Validation of m6A-Related lncRNA Signature as Potential Predictive Biomarkers in Breast Cancer
por: Lv, Wenchang, et al.
Publicado: (2021)

Identification and validation of an anoikis-related lncRNA signature to predict prognosis and immune landscape in osteosarcoma
por: Zhang, Jun-Song, et al.
Publicado: (2023)

Development and Validation of an Autophagy-Related LncRNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Shen, Lin, et al.
Publicado: (2021)

Identification and Validation of a Novel Immune-Related lncRNA Signature for Bladder Cancer
por: Hua, Shan, et al.
Publicado: (2021)

Identification and Validation of an Immune-Related lncRNA Signature to Facilitate Survival Prediction in Gastric Cancer
por: Ma, Ensi, et al.
Publicado: (2021)

Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Lianghao, et al.
Publicado: (2021)

Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma
por: Zhu, Jinfeng, et al.
Publicado: (2022)

Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients
por: Jiang, Zi-Rong, et al.
Publicado: (2022)

Identification of a Glycolysis-Related LncRNA Signature to Predict Survival in Diffuse Glioma Patients
por: Wang, Yangyang, et al.
Publicado: (2021)

An autophagy-related four-lncRNA signature helps to predict progression-free survival of neuroblastoma patients
por: Wang, Jing, et al.
Publicado: (2022)

Identification and Validation of a Stromal EMT Related LncRNA Signature as a Potential Marker to Predict Bladder Cancer Outcome
por: Du, YiHeng, et al.
Publicado: (2021)

LncRNA PELATON, a Ferroptosis Suppressor and Prognositic Signature for GBM
por: Fu, Haijuan, et al.
Publicado: (2022)

Identification and Validation of a Novel Six-lncRNA-Based Prognostic Model for Lung Adenocarcinoma
por: Yang, Lingge, et al.
Publicado: (2022)

Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis
por: Huang, Hua, et al.
Publicado: (2022)

Identification and validation of stemness-related lncRNA prognostic signature for breast cancer
por: Li, Xiaoying, et al.
Publicado: (2020)

Identification and Validation of an m6A-Related LncRNA Signature to Predict Progression-Free Survival in Colorectal Cancer
por: Zhang, Yong, et al.
Publicado: (2022)

Comparison of Stage 4 and Stage 4s Neuroblastoma Identifies Autophagy-Related Gene and LncRNA Signatures Associated With Prognosis
por: Meng, Xinyao, et al.
Publicado: (2020)

Derivation, Comprehensive Analysis, and Assay Validation of a Pyroptosis-Related lncRNA Prognostic Signature in Patients With Ovarian Cancer
por: Cao, Xueyan, et al.
Publicado: (2022)

Cancer-associated fibroblasts-derived lncRNA signature as a putative biomarker in breast cancer
por: Li, Zan, et al.
Publicado: (2022)

Identification of a Ferroptosis-Related LncRNA Signature as a Novel Prognosis Model for Lung Adenocarcinoma
por: Lu, Lu, et al.
Publicado: (2021)

A Novel Nine-lncRNA Risk Signature Correlates With Immunotherapy in Hepatocellular Carcinoma
por: Nie, Ye, et al.
Publicado: (2021)

Identification and Validation of a Novel Immune-Related Four-lncRNA Signature for Lung Adenocarcinoma
por: Wang, Jixin, et al.
Publicado: (2021)

Comprehensive Analysis of a Ferroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Landscape in Osteosarcoma
por: Zhang, Yiming, et al.
Publicado: (2022)

Genomic Instability-Related LncRNA Signature Predicts the Prognosis and Highlights LINC01614 Is a Tumor Microenvironment-Related Oncogenic lncRNA of Papillary Thyroid Carcinoma
por: Dong, Xubin, et al.
Publicado: (2021)

A Signature of Nine lncRNA Methylated Genes Predicts Survival in Patients With Glioma
por: Cheng, Meng, et al.
Publicado: (2021)

A novel glycosyltransferase-related lncRNA signature correlates with lung adenocarcinoma prognosis
por: Bian, Chengyu, et al.
Publicado: (2022)

Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma
por: Xu, Miaorong, et al.
Publicado: (2022)

Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma
por: Yin, Zhengrong, et al.
Publicado: (2022)

Identification and validation of an immune-related lncRNAs signature to predict the overall survival of ovarian cancer
por: Li, He, et al.
Publicado: (2022)

Identification and Validation of lncRNA-SNHG17 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator
por: Li, Xinyan, et al.
Publicado: (2022)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Identification of pyroptosis-related lncRNA signature and AC005253.1 as a pyroptosis-related oncogene in prostate cancer
por: Yu, JiangFan, et al.
Publicado: (2022)

Identification and validation of immune‐related lncRNA prognostic signatures for melanoma
por: Xiao, Bo, et al.
Publicado: (2021)

Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Ze-Kun, et al.
Publicado: (2022)

Sonographic Features of Triple-Negative Breast Carcinomas Are Correlated With mRNA–lncRNA Signatures and Risk of Tumor Recurrence
por: Li, Jia-wei, et al.
Publicado: (2021)

Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma
por: Zhang, Pengpeng, et al.
Publicado: (2023)

Identification and validation of a prognostic immune-related lncRNA signature in bladder cancer
por: Zhao, Kai, et al.
Publicado: (2021)

Identification and Characterization of TF-lncRNA Regulatory Networks Involved in the Tumorigenesis and Development of Adamantinomatous Craniopharyngioma
por: Xu, Dingkang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_viep1n07ppsigjpcduuv6u8a9h